Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229153 | SCV000284467 | likely benign | Neurofibromatosis, type 1 | 2024-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317752 | SCV000670541 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2024-07-18 | criteria provided, single submitter | clinical testing | The p.W1491C variant (also known as c.4473G>C), located in coding exon 33 of the NF1 gene, results from a G to C substitution at nucleotide position 4473. The tryptophan at codon 1491 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV000229153 | SCV002560442 | uncertain significance | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003322763 | SCV004028390 | uncertain significance | not provided | 2023-02-21 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 29617658, 22807134) |
Baylor Genetics | RCV003463651 | SCV004198371 | uncertain significance | Juvenile myelomonocytic leukemia | 2023-08-13 | criteria provided, single submitter | clinical testing |